Growth Metrics

Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2025)

Organogenesis Holdings has reported Long-Term Deferred Tax over the past 9 years, most recently at $30.0 million for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $30.0 million for Q4 2025, down 24.07% from a year ago — trailing twelve months through Dec 2025 was $30.0 million (down 24.07% YoY), and the annual figure for FY2025 was $30.0 million, down 24.07%.
  • Long-Term Deferred Tax for Q4 2025 was $30.0 million at Organogenesis Holdings, down from $45.6 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for ORGO hit a ceiling of $45.6 million in Q3 2025 and a floor of $18000.0 in Q1 2021.
  • Median Long-Term Deferred Tax over the past 5 years was $31.0 million (2021), compared with a mean of $28.6 million.
  • Biggest five-year swings in Long-Term Deferred Tax: soared 177644.44% in 2021 and later fell 24.07% in 2025.
  • Organogenesis Holdings' Long-Term Deferred Tax stood at $32.0 million in 2021, then fell by 6.19% to $30.0 million in 2022, then fell by 6.7% to $28.0 million in 2023, then surged by 40.93% to $39.5 million in 2024, then fell by 24.07% to $30.0 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $30.0 million (Q4 2025), $45.6 million (Q3 2025), and $41.8 million (Q2 2025) per Business Quant data.